Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome

Allogeneic stem cell transplantation (alloSCT) represents a curative therapeutic option for patients with myelodysplastic syndrome (MDS), but relapse and non-relapse mortality (NRM) limit treatment efficacy. Based on our previous observation in acute myeloid leukemia we investigated the impact of pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Radujkovic, Aleksandar, Becker, Natalia, Benner, Axel, Penack, Olaf, Platzbecker, Uwe, Stölzel, Friedrich, Bornhäuser, Martin, Hegenbart, Ute, Ho, Anthony D., Dreger, Peter, Luft, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741512/
https://www.ncbi.nlm.nih.gov/pubmed/26360778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741512/
https://www.ncbi.nlm.nih.gov/pubmed/26360778

Ejemplares similares